246 related articles for article (PubMed ID: 23820312)
1. Non-convulsive status epilepticus associated with glutamic acid decarboxylase antibody.
Cikrikçili U; Ulusoy C; Turan S; Yildiz S; Bilgiç B; Hanagasi H; Baykan B; Tüzün E; Gürvit H
Clin EEG Neurosci; 2013 Jul; 44(3):232-6. PubMed ID: 23820312
[TBL] [Abstract][Full Text] [Related]
2. Refractory status epilepticus and glutamic acid decarboxylase antibodies in adults: presentation, treatment and outcomes.
Khawaja AM; Vines BL; Miller DW; Szaflarski JP; Amara AW
Epileptic Disord; 2016 Mar; 18(1):34-43. PubMed ID: 26878120
[TBL] [Abstract][Full Text] [Related]
3. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus.
Lin JJ; Lin KL; Hsia SH; Wang HS; Chou IJ; Lin YT;
Pediatr Neurol; 2012 Oct; 47(4):252-8. PubMed ID: 22964438
[TBL] [Abstract][Full Text] [Related]
4. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
[TBL] [Abstract][Full Text] [Related]
5. Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitus.
Bayreuther C; Hieronimus S; Ferrari P; Thomas P; Lebrun C
Diabetes Metab; 2008 Sep; 34(4 Pt 1):386-8. PubMed ID: 18583169
[TBL] [Abstract][Full Text] [Related]
6. Opercular myoclonic-anarthric status epilepticus due to glutamic acid decarboxylase antibody-associated encephalitis.
Monnerat BZ; Velasco TR; Nakano FN; Júnior AV; Martins AP; Sakamoto AC
Epileptic Disord; 2013 Sep; 15(3):342-6. PubMed ID: 23981587
[TBL] [Abstract][Full Text] [Related]
7. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality?
Blanc F; Ruppert E; Kleitz C; Valenti MP; Cretin B; Humbel RL; Honnorat J; Namer IJ; Hirsch E; Manning L; de Seze J
J Neurol Sci; 2009 Dec; 287(1-2):69-71. PubMed ID: 19786284
[TBL] [Abstract][Full Text] [Related]
8. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA).
Lohmann T; Kellner K; Verlohren HJ; Krug J; Steindorf J; Scherbaum WA; Seissler J
Diabetologia; 2001 Aug; 44(8):1005-10. PubMed ID: 11484077
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
[TBL] [Abstract][Full Text] [Related]
10. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
[TBL] [Abstract][Full Text] [Related]
12. GAD65-Ab encephalitis and subtle focal status epilepticus.
Goudot M; Frismand S; Hopes L; Verger A; Joubert B; Honnorat J; Tyvaert L
Epileptic Disord; 2019 Oct; 21(5):437-442. PubMed ID: 31649008
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.
Manto MU; Laute MA; Aguera M; Rogemond V; Pandolfo M; Honnorat J
Ann Neurol; 2007 Jun; 61(6):544-51. PubMed ID: 17600364
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus.
Kanter IC; Huttner HB; Staykov D; Biermann T; Struffert T; Kerling F; Hilz MJ; Schellinger PD; Schwab S; Bardutzky J
Epilepsia; 2008 May; 49(5):914-20. PubMed ID: 18177354
[TBL] [Abstract][Full Text] [Related]
15. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
Reinsch B; Zimmy S; Schatz H; Pfohl M
Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
[TBL] [Abstract][Full Text] [Related]
16. [Islet beta cell function in latent autoimmune diabetes in adults with islet cell antibodies].
Yang L; Zhou ZG; Huang G; Yan X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Jun; 29(3):309-14. PubMed ID: 16136967
[TBL] [Abstract][Full Text] [Related]
17. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
Huang YY; Huang P; Lou HL
Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
[TBL] [Abstract][Full Text] [Related]
18. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
De Aizpurua HJ; French MB; Chosich N; Harrison LC
J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
[TBL] [Abstract][Full Text] [Related]
19. Glutamic acid decarboxylase autoantibodies and neurological disorders.
Vianello M; Tavolato B; Giometto B
Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
[TBL] [Abstract][Full Text] [Related]
20. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
